Comparison between formoterol 12 μ g b.i.d. and on-demand salbutamol in moderate persistent asthma
- 31 January 2001
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 95 (1) , 64-70
- https://doi.org/10.1053/rmed.2000.0972
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severityJournal of Allergy and Clinical Immunology, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Asthma and the beta agonist debate.Thorax, 1995
- *Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway diseaseAllergy, 1995
- Regular vs as-needed inhaled salbutamol in asthma controlPublished by Elsevier ,1994
- Formoterol, a New Long-Acting ß2 Agonist, Inhaled Twice Daily, in Stable Asthmatic SubjectsChest, 1992
- The St George's Respiratory QuestionnaireRespiratory Medicine, 1991
- FormoterolDrugs, 1991
- Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.Thorax, 1990